obial therapy [3]. However, the risk of fungal co-infection, in particular COVID-19 associated pulmonary aspergillosis (CAPA), remains underappreciated.

Cases of COVID-19 associated pulmonary aspergillosis (CAPA) are being increasingly reported and p